PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+14.25%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$3.56B
AUM Growth
+$3.56B
(+18%)
Cap. Flow
+$344M
Cap. Flow
% of AUM
9.68%
Top 10 Holdings %
Top 10 Hldgs %
49.76%
Holding
165
New
31
Increased
30
Reduced
29
Closed
32
Top Buys
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$97.4M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$64.9M |
| 3 |
Ascendis Pharma
ASND
|
$64.3M |
| 4 |
VYNE Therapeutics
VYNE
|
$60.1M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
$34.2M |
Top Sells
| 1 |
AnaptysBio
ANAB
|
$54M |
| 2 |
Neurocrine Biosciences
NBIX
|
$32.3M |
| 3 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$25.2M |
| 4 |
Intuitive Surgical
ISRG
|
$25M |
| 5 |
Zimmer Biomet
ZBH
|
$24.1M |
Sector Composition
| 1 | Healthcare | 96.13% |
| 2 | Consumer Discretionary | 0.06% |
| 3 | Industrials | 0.02% |
| 4 | Technology | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VBIV
26
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $33.8M | 0.95% |
9,665,843
| – | – |
|
|
CBAY
27
DELISTED
Cymabay Therapeutics
CBAY
| $33.7M | 0.95% |
2,802,821
+116,939
| +4% | +$1.41M |
|
28
uniQure
QURE
$954M
| $32.8M | 0.92% |
1,394,628
+346,678
| +33% | +$8.15M |
|
29
Puma Biotechnology
PBYI
$258M
| $30.1M | 0.84% |
442,179
-261,641
| -37% | -$17.8M |
|
|
QTNT
30
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $28.4M | 0.8% |
6,033,020
| – | – |
|
31
iRhythm Technologies
IRTC
$5.67B
| $26.4M | 0.74% |
419,706
-7,665
| -2% | -$483K |
|
32
Regenxbio
RGNX
$498M
| $26.3M | 0.74% |
881,106
-540,080
| -38% | -$16.1M |
|
33
Vertex Pharmaceuticals
VRTX
$102B
| $24.8M | 0.69% |
151,898
+13,272
| +10% | +$2.16M |
|
|
34
AnaptysBio
ANAB
$630M
| $24.7M | 0.69% |
237,281
-519,106
| -69% | -$54M |
|
|
NEPT
35
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
| $24.1M | 0.67% |
8,574,015
+200,000
| +2% | +$563K |
|
36
Akebia Therapeutics
AKBA
$827M
| $23.5M | 0.66% |
2,462,400
+475,000
| +24% | +$4.53M |
|
37
Assembly Biosciences
ASMB
$183M
| $23.4M | 0.66% |
476,626
-60,000
| -11% | -$2.95M |
|
38
Aldeyra Therapeutics
ALDX
$350M
| $23.1M | 0.65% |
3,085,458
| – | – |
|
|
BOLD
39
DELISTED
Audentes Therapeutics, Inc
BOLD
| $22.7M | 0.64% |
756,215
-25,094
| -3% | -$754K |
|
|
KDMN
40
DELISTED
Kadmon Holdings, Inc.
KDMN
| $22M | 0.61% |
5,165,746
-20,101
| -0.4% | -$85.4K |
|
41
Teladoc Health
TDOC
$1.37B
| $21M | 0.59% |
+520,000
| New | +$21M |
|
42
Galapagos
GLPG
$2.06B
| $20.6M | 0.58% |
206,305
| – | – |
|
43
Agios Pharmaceuticals
AGIO
$2.36B
| $20.4M | 0.57% |
+250,000
| New | +$20.4M |
|
|
ABLX
44
DELISTED
Ablynx NV American Depositary Shares
ABLX
| $20.2M | 0.57% |
370,000
+120,000
| +48% | +$6.55M |
|
|
ECYT
45
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $20M | 0.56% |
2,201,700
+750,000
| +52% | +$6.82M |
|
|
RVNC
46
DELISTED
Revance Therapeutics, Inc.
RVNC
| $19.1M | 0.53% |
618,957
+218,957
| +55% | +$6.74M |
|
47
Wave Life Sciences
WVE
$1.27B
| $18.6M | 0.52% |
462,798
-200,000
| -30% | -$8.02M |
|
48
ADMA Biologics
ADMA
$4.03B
| $17.6M | 0.49% |
3,821,102
| – | – |
|
49
Madrigal Pharmaceuticals
MDGL
$9.7B
| $16.6M | 0.47% |
142,522
-46,371
| -25% | -$5.42M |
|
50
Humana
HUM
$37.5B
| $16.3M | 0.46% |
60,718
-16,782
| -22% | -$4.51M |
|